Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-DR restricted peptide candidates for bee venom immunotherapy.

Journal of immunology (Baltimore, Md. : 1950) - 15 Mar 2000

Texier C, Pouvelle S, Busson M, Hervé M, Charron D, Ménez A, Maillère B

Abstract excerpt

T cell epitopes containing peptides have been recently proposed as an alternative to conventional immunotherapy of allergic diseases because they are expected to be better tolerated than allergen extracts. A principal limitation to their clinical use is that they present an important diversity, which primarily results from the polymorphism of HLA class II molecules. In Caucasian populations, however, seven...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptide Fragments
Share to Amino Acid Sequence
Share to Desensitization, Immunologic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epitopes

Share to HLA-DR Antigens

Share to Polymorphism, Genetic

Share to Protein Binding

Share to White People

Source

Identifiers

PMID: 10706708
DOI: 10.4049/jimmunol.164.6.3177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-DR restricted peptide candidates for bee venom immunotherapy.PMID 10706708Read ↗

Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.Semantic proximity Read ↗

Several common HLA-DR types share largely overlapping peptide binding repertoires.Semantic proximity Read ↗

Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.Semantic proximity Read ↗

Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons.Semantic proximity Read ↗

Diversity of human T cell receptor sequences of T cell clones with specificity for Bet v 1 peptide/MHC II complexes.Semantic proximity Read ↗

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.Semantic proximity Read ↗

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.Semantic proximity Read ↗

Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.Semantic proximity Read ↗

The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis.Semantic proximity Read ↗

On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.Semantic proximity Read ↗

Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers.Semantic proximity Read ↗

A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.